A novel CLPP variant in a Pakistani family with Perrault syndrome associated with recurrent fevers
Clinica Chimica Acta · 2026-03 · 583 · 120832
DOI: 10.1016/j.cca.2026.120832 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinica Chimica Acta, 2026-03. Verfasst von Nisar Ahmad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Furong Laboratory, Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, PR China; MOE Key Laboratory of R…. Hauptthemen laut MEDLINE: Endopeptidase Clp, Gonadal Dysgenesis, 46,XX, Hearing Loss, Sensorineural, Fever. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Central South University, National Natural Science Foundation of China, Hunan Provincial Natural Science Foundation.
Abstract (Originalsprache)
Perrault syndrome (PRLTS) is an autosomal recessive disease with sensorineural hearing loss and ovarian dysfunction in girls, and either a fluctuating neurological phenotype or not. PRLTS type 2 is known to be caused by pathogenic variants of the CLPP gene that encodes mitochondrial ATP-dependent protease. This paper involved clinical and genetic studies on a Pakistani family with PRLTS. Whole-exome sequencing identified a novel homozygous CLPP missense mutation (NM_006012.4: c.250 A > C; p.Ile84Leu). Its pathogenicity was assessed with the help of multiple sequence alignment, AlphaFold protein modeling, and docking with CLPX with the help of ClusPro. Auditory brainstem responses and tympanometry were in clinical assessment. The individuals were found to have a uniform phenotype of severe sensorineural hearing loss, mild intellectual disability, ataxia and frequent fever. There was one patient in whom the unilateral Eustachian tube dysfunction was hinted at by Tympanometry. At the molecular level, the identified CLPP variant involved a highly conserved residue. Structural modeling showed preserved protein architecture, whereas docking simulations revealed disrupted CLPP-CLPX interaction, suggesting a basis for impaired proteostasis. We report a novel CLPP missense variant (p.I84L) in a Pakistani family with PRLTS, expanding the mutational spectrum of CLPP. To the best of our knowledge, recurrent fever was reported in PRLTS for the first time, which expanded the PRLTS phenotype spectrum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Furong Laboratory, Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, PR China; MOE Key Laboratory of Rare Pediatric Diseases, Changsha, Hunan, PR China; Hunan Key Laborator…
- Gomal Centre of Biochemistry and Biotechnology, Gomal University, Dera Ismail Khan, Pakistan.
- Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, PR China.
- Department of Nutrition, Xiangya Hospital, Central South University, Xiangya road, Changsha, Hunan, PR China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, Hunan 410008, PR China…
Förderung
- Central South University
- National Natural Science Foundation of China
- Hunan Provincial Natural Science Foundation
Zitieren
APA
Ahmad, N., Zhang, P., Muzammal, M., Shah, W., Ran, L., Niaz, M., Li, J. D., & Men, M. (2026). A novel CLPP variant in a Pakistani family with Perrault syndrome associated with recurrent fevers. Clinica Chimica Acta, 583, 120832. https://doi.org/10.1016/j.cca.2026.120832
Vancouver
Ahmad N, Zhang P, Muzammal M, Shah W, Ran L, Niaz M, et al. A novel CLPP variant in a Pakistani family with Perrault syndrome associated with recurrent fevers. Clinica Chimica Acta. 2026;583:120832. doi:10.1016/j.cca.2026.120832
BibTeX
@article{Ahmad2026,
author = {Ahmad, Nisar and Zhang, Pingchuan and Muzammal, Muhammad and Shah, Wasim and Ran, Li and Niaz, Maryam and Li, Jia-Da and Men, Meichao},
title = {A novel CLPP variant in a Pakistani family with Perrault syndrome associated with recurrent fevers},
journal = {Clinica Chimica Acta},
year = {2026},
volume = {583},
pages = {120832},
doi = {10.1016/j.cca.2026.120832}
}
EUVIMED